Cumberland Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Cumberland Pharmaceuticals

10/08/2021 23:58

* Cumberland Pharmaceuticals Inc  CPIX.OQ  reported quarterly
breakeven results​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of 7 cents
per share.
* Revenue fell 5.7% to $9.06 million from a year ago;  analysts
expected $8.57 million. 
* Cumberland Pharmaceuticals Inc's reported EPS for the quarter
was 8 cents​.
* The mean earnings estimate of analysts had fallen by
about 800% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Cumberland Pharmaceuticals Inc shares had fallen by 0.9% this
quarter and lost 4.4% so far this year.
* The company reported quarterly net income of $1.23 million.
* Wall Street's median 12-month price target for Cumberland
Pharmaceuticals Inc is $8.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 10:58 p.m.  ​All
figures in US dollars unless otherwise stated